Comparative Study
doi: 10.1007/978-1-4615-7192-6_10.
Comparative antioestrogen action in experimental breast cancer
- PMID: 6805259
- DOI: 10.1007/978-1-4615-7192-6_10
Item in Clipboard
Comparative Study
Comparative antioestrogen action in experimental breast cancer
Adv Exp Med Biol.
1981.
No abstract available
Similar articles
-
Anti-oestrogen action in experimental breast cancer.Recent Results Cancer Res. 1980;71:30-44. doi: 10.1007/978-3-642-81406-8_8. Recent Results Cancer Res. 1980. PMID: 6768113 Review. No abstract available.
-
A comparison of the efficacy for antitumor activity of the non-steroidal antiestrogens analog II and tamoxifen in 7,12-dimethylbenz[a] anthracene-induced rat mammary tumors.Cancer Lett. 1982 Mar-Apr;15(3):261-9. doi: 10.1016/0304-3835(82)90127-6. Cancer Lett. 1982. PMID: 6811128 No abstract available.
-
Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.Eur J Cancer (1965). 1980 Feb;16(2):239-51. doi: 10.1016/0014-2964(80)90156-5. Eur J Cancer (1965). 1980. PMID: 6768559 No abstract available.
-
Independent regulation of growth and steroid receptors in uterus and mammary tumors of rats.Anticancer Res. 1983 Nov-Dec;3(6):385-91. Anticancer Res. 1983. PMID: 6230984
-
Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.Breast Cancer Res Treat. 1983;3 Suppl:S73-86. doi: 10.1007/BF01855131. Breast Cancer Res Treat. 1983. PMID: 6423014 Review.
Cited by
-
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer.Br J Cancer. 1989 Jul;60(1):126-31. doi: 10.1038/bjc.1989.235. Br J Cancer. 1989. PMID: 2679843 Free PMC article. Clinical Trial.
-
A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models.Res Sq [Preprint]. 2023 Oct 23:rs.3.rs-3459372. doi: 10.21203/rs.3.rs-3459372/v1. Res Sq. 2023. Update in: Sci Rep. 2025 Jan 24;15(1):3028. doi: 10.1038/s41598-024-77186-z. PMID: 37961240 Free PMC article. Updated. Preprint.
-
Chemoprevention of breast cancer.Breast Cancer Res Treat. 1989 Oct;14(1):23-31. doi: 10.1007/BF01805972. Breast Cancer Res Treat. 1989. PMID: 2690969 Clinical Trial.
-
Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant.Sci Rep. 2025 Jan 24;15(1):3028. doi: 10.1038/s41598-024-77186-z. Sci Rep. 2025. PMID: 39848945 Free PMC article.